{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:52:06Z","timestamp":1789901526830,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.expneurol.2007.11.022","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T14:48:06Z","timestamp":1196866086000},"page":"421-427","source":"Crossref","is-referenced-by-count":81,"title":["Rasagiline is neuroprotective in a transgenic model of multiple system atrophy"],"prefix":"10.1016","volume":"210","author":[{"given":"Nadia","family":"Stefanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Poewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor K.","family":"Wenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2007.11.022_bib1","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1096\/fj.05-3794fje","article-title":"Regulation of Bcl-2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine","volume":"19","author":"Bar-Am","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2007.11.022_bib2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1471-4159.2004.02425.x","article-title":"Regulation of protein kinase C by the anti-Parkinson drug, MAO-B inhibitor, rasagiline and its derivatives, in vivo","volume":"89","author":"Bar-Am","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2007.11.022_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.expneurol.2004.03.005","article-title":"Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease","volume":"187","author":"Blandini","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.11.022_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","article-title":"Replicating Huntington's disease phenotype in experimental animals","volume":"59","author":"Brouillet","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2007.11.022_bib5","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/0091270005277935","article-title":"Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease","volume":"45","author":"Chen","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.expneurol.2007.11.022_bib6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00702-004-0254-4","article-title":"Neuroprotective effect of rasagiline, a monoamine oxidase-B inhibitor, on spontaneous cell degeneration in a rat model","volume":"112","author":"Eliash","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2007.11.022_bib7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s007020170012","article-title":"Rasagiline and its (S) enantiomer increase survival and prevent stroke in salt-loaded stroke-prone spontaneously hypertensive rats","volume":"108","author":"Eliash","year":"2001","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2007.11.022_bib8","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0306-4522(02)00205-1","article-title":"Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57B1\/6 mice: behavioural and histopathological characterisation","volume":"114","author":"Fernagut","year":"2002","journal-title":"Neuroscience"},{"issue":"Suppl 12","key":"10.1016\/j.expneurol.2007.11.022_bib9","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1002\/mds.20541","article-title":"In vivo models of multiple system atrophy","volume":"20","author":"Fernagut","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2007.11.022_bib10","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0028-3908(02)00216-2","article-title":"Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours","volume":"43","author":"Finberg","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2007.11.022_bib11","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0306-4522(01)00230-5","article-title":"Degeneration of neurons and glia in the Niemann\u2013Pick C mouse is unrelated to the low-density lipoprotein receptor","volume":"105","author":"German","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2007.11.022_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(85)90168-2","article-title":"Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-B","volume":"116","author":"Heikkila","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2007.11.022_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(98)00929-7","article-title":"Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse","volume":"366","author":"Huang","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2007.11.022_bib14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/embo-reports\/kvf109","article-title":"Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes","volume":"3","author":"Kahle","year":"2002","journal-title":"EMBO Rep."},{"key":"10.1016\/j.expneurol.2007.11.022_bib15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0306-4522(00)00326-2","article-title":"Immunohistochemical localization of glial cell line-derived neurotrophic factor in the human central nervous system","volume":"100","author":"Kawamoto","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2007.11.022_bib16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s007020170018","article-title":"Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline","volume":"108","author":"Kupsch","year":"2001","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2007.11.022_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.molbrainres.2004.10.033","article-title":"3-nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by Bcl-2 overexpression in PC12 cells","volume":"133","author":"Mandavilli","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2007.11.022_bib18","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1007\/s11064-007-9351-8","article-title":"Rasagiline promotes regeneration of substantia nigra dopaminergic neurons in post-MPTP-induced Parkinsonism via activation of tyrosine kinase receptor signaling pathway","volume":"32","author":"Mandel","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2007.11.022_bib19","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1001\/archneur.59.12.1937","article-title":"A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study","volume":"59","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2007.11.022_bib20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archneur.61.4.561","article-title":"A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease","volume":"61","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2007.11.022_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2006.07.020","article-title":"Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism","volume":"25","author":"Sagi","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2007.11.022_bib22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s007020050182","article-title":"Studies with rasagiline, a MAO-B inhibitor, in experimental focal ischemia in the rat","volume":"106","author":"Speiser","year":"1999","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2007.11.022_bib23","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0002-9440(10)62307-3","article-title":"Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy","volume":"166","author":"Stefanova","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2007.11.022_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/mds.21671","article-title":"Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: Implications for multiple system atrophy","author":"Stefanova","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2007.11.022_bib25","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1592\/phco.24.14.1295.43156","article-title":"Tolerability, safety, pharmacodynamics, and pharmacokinetics of rasagiline: a potent, selective, and irreversible monoamine oxidase type B inhibitor","volume":"24","author":"Thebault","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.expneurol.2007.11.022_bib26","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1523\/JNEUROSCI.17-10-03554.1997","article-title":"Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS","volume":"17","author":"Trupp","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2007.11.022_bib27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.0305-1846.2001.00305.x","article-title":"The mitochondrial toxin 3-nitropropionic acid induces differential expression patterns of apoptosis-related markers in rat striatum","volume":"27","author":"Vis","year":"2001","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2007.11.022_bib28","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1007\/s00415-004-0481-5","article-title":"Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model","volume":"251","author":"Waibel","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2007.11.022_bib29","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1096\/fj.04-1916fje","article-title":"Neuroprotection via pro-survival protein kinase C isoforms associated with Bcl-2 family members","volume":"18","author":"Weinreb","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2007.11.022_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1474-4422(03)00662-8","article-title":"Multiple system atrophy","volume":"3","author":"Wenning","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2007.11.022_bib31","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1096\/fj.03-0078fje","article-title":"The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives in MAPK-dependent amyloid precursor protein processing","volume":"17","author":"Yogev-Falach","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2007.11.022_bib32","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0006-2952(03)00535-5","article-title":"The essentiality of Bcl-2, PKC and proteasome-ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline","volume":"66","author":"Youdim","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.expneurol.2007.11.022_bib33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/sj.bjp.0703826","article-title":"Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B","volume":"132","author":"Youdim","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2007.11.022_bib34","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1023\/A:1015131516649","article-title":"Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate]","volume":"21","author":"Youdim","year":"2001","journal-title":"Cell Mol. Neurobiol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488607004311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488607004311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T15:13:16Z","timestamp":1557069196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488607004311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0014488607004311"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2007.11.022","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}